Abstract
Intestinal obstruction is very common in cancer patients and occurs in 80% of cases with malignant aetiology. Hence, aggressive treatment is needed in most cases. The occlusion can be caused by luminal obstruction, paralysis of the intestinal muscle or carcinomatosis with mesentery involvement. The clinical case we present is that of a patient diagnosed as having lung cancer and who was admitted with paralytic ileus following treatment with vinorelbine; a vinca alkaloid whose main characteristic toxicities include neutropenia and peripheral neuropathy. Also, on rare occasions, the drug can cause paralysis of the ileum due to autonomic neuropathy. Hence, before administering aggressive treatment to an occlusive syndrome, cases that could benefit from conservative treatment should be ruled out.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Bibliografía
Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer. 2002;12: 135–43.
González Barón M. Oncología clínica fundamentos y patología general. 2. ed. Madrid: McGraw-Hill interamericana; 1998.
Ripamonti C, DeConno F. Management of bowel obstruction in advanced and terminal cancer patients. Annals of Oncology. 1993;4:15–21.
Sarah L, Blair MD. Outcome of palliative operatinos for malignant bowel obstruction in patients with peritoneal carcinomatosis. Ann Surg Oncol. 2001;8(8):632–7.
Baines M, Oliver DJ. Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet. 1985;2:990–3.
Lonardi F, Pavanato G, Ferrari V. Neurotoxicity after chemotherapy with vinorelbine. Eur J Cancer. 1993; 29(A)12:1794.
Baldini E, Tibaldi C. Epirrubicin navelbine as first line therapy in metastatic breast cancer. Breast Cancer Res Treat. 1998;49(2):129–34.
Casamati M, Ferrari A. Vinorelbine in previously treated advanced sarcoma. Cancer. 2002;94:12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galiana, G.E., García, H.B., Ferrándiz, C.L. et al. Íleo paralítico por vinorelbina. Clin Transl Oncol 7, 169–170 (2005). https://doi.org/10.1007/BF02708755
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02708755
Key words
- intestinal obstruction aetiology
- ileus
- vinca alkaloids analogues and derivatives
- lung neoplasms
- antineoplastic combined chemotherapy protocols